$ Value
$0
Shares
42,875
Price
$0
Filed
Feb 10
Insider
Name
Hansen Gwenn
Title
Chief Scientific Officer
CIK
0001817160
Roles
Transaction Details
Transaction Date
2026-02-10
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
42,875
Footnotes
The stock option vests as to 1/36 of the total shares monthly beginning March 10, 2026, until the option is fully vested on February 9, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. | RSUs do not expire; they either vest or are canceled prior to the vest date.
Filing Info
Hansen Gwenn's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | NRIX | A | $0 |
| 2026-02-10 | NRIX | A | $0 |
| 2026-02-03 | NRIX | M | $26K |
| 2026-02-03 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | ▼ | $80K |
| 2026-01-30 | NRIX | ▼ | $2K |
Other Insiders at NRIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SANDS ARTHUR T
President, CEO
|
— | — | 2026-02-10 |
|
Hansen Gwenn
Chief Scientific Officer
|
— | $81K | 2026-02-10 |
|
Ring Christine
Chief Legal Officer
|
— | $561K | 2026-04-02 |
|
van Houte Hans
Chief Financial Officer
|
— | $61K | 2026-02-10 |